BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE: 848 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
848
Total FAERS Reports
15 (1.8%)
Deaths Reported
304
Hospitalizations
848
As Primary/Secondary Suspect
28
Life-Threatening
44
Disabilities
Active Ingredient: BISMUTH SUBCITRATE POTASSIUM\METRONIDAZOLE\TETRACYCLINE HYDROCHLORIDE ·
First Report: 2013 · Latest Report: 20250819
What Are the Most Common BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE Side Effects?
#1 Most Reported
Nausea
101 reports (11.9%)
#2 Most Reported
Headache
92 reports (10.8%)
#3 Most Reported
Diarrhoea
81 reports (9.6%)
All BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 101 | 11.9% | 0 | 25 |
| Headache | 92 | 10.9% | 0 | 30 |
| Diarrhoea | 81 | 9.6% | 1 | 23 |
| Dizziness | 62 | 7.3% | 1 | 12 |
| Asthenia | 60 | 7.1% | 0 | 12 |
| Vomiting | 59 | 7.0% | 0 | 23 |
| Faeces discoloured | 58 | 6.8% | 0 | 6 |
| Off label use | 56 | 6.6% | 0 | 14 |
| Pruritus | 55 | 6.5% | 0 | 23 |
| Dyspnoea | 42 | 5.0% | 1 | 13 |
| Vertigo | 42 | 5.0% | 1 | 8 |
| Abdominal pain upper | 39 | 4.6% | 0 | 12 |
| Pyrexia | 39 | 4.6% | 1 | 28 |
| Decreased appetite | 37 | 4.4% | 0 | 7 |
| Abdominal pain | 36 | 4.3% | 0 | 14 |
| Paraesthesia | 36 | 4.3% | 0 | 12 |
| Fatigue | 35 | 4.1% | 0 | 4 |
| Malaise | 35 | 4.1% | 2 | 6 |
| Dysgeusia | 32 | 3.8% | 0 | 2 |
| Anxiety | 31 | 3.7% | 0 | 14 |
Who Reports BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE Side Effects? Age & Gender Data
Gender: 64.1% female, 35.9% male. Average age: 52.5 years. Most reports from: FR. View detailed demographics →
Is BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 10 | 1 | 5 |
| 2014 | 40 | 0 | 15 |
| 2015 | 36 | 1 | 14 |
| 2016 | 60 | 2 | 27 |
| 2017 | 75 | 0 | 24 |
| 2018 | 58 | 0 | 23 |
| 2019 | 75 | 0 | 27 |
| 2020 | 71 | 0 | 36 |
| 2021 | 63 | 0 | 12 |
| 2022 | 54 | 1 | 21 |
| 2023 | 64 | 1 | 37 |
| 2024 | 45 | 9 | 12 |
| 2025 | 16 | 0 | 11 |
What Is BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE Used For?
| Indication | Reports |
|---|---|
| Helicobacter infection | 506 |
| Helicobacter gastritis | 130 |
| Product used for unknown indication | 105 |
| Gastritis | 17 |
| Gastric ulcer helicobacter | 12 |
| Helicobacter test positive | 12 |
| Peptic ulcer | 10 |
| Gastric ulcer | 8 |
| Ulcer | 7 |
| Gastroduodenal ulcer | 5 |
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs Alternatives: Which Is Safer?
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BISMUTH SUBSALICYLATE
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BISMUTH SUBSALICYLATE\METRONIDAZOLE\TETRACYCLINE
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BISOPROLOL
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BISOPROLOL\BISOPROLOL
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BISOPROLOL\HYDROCHLOROTHIAZIDE
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BIVALIRUDIN
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BLEOMYCIN
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BLINATUMOMAB
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs BLONANSERIN
BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
Official FDA Label for BISMUTH SUBCITRATE\METRONIDAZOLE\TETRACYCLINE
Official prescribing information from the FDA-approved drug label.